Genetic Disorders and the Ethical Status of Germ-Line Gene Therapy

Journal of Medicine and Philosophy 16 (6):667-683 (1991)
  Copy   BIBTEX

Abstract

Recombinant DNA technology will soon allow physicians an opportunity to carry out both somatic cell- and Germ-Line gene therapy. While somatic cell gene therapy raises no new ethical problems, gene therapy of gametes, fertilized eggs or early embryos does raise several novel concerns. The first issue discussed here relates to making a distinction between negative and positive eugenics; the second issue deals with the evolutionary consequences of lost genetic diversity. In distinguishing between positive and negative eugenics, the concept of malady is applied as a definitional criterion for identifying genetic disorders that could qualify for Germ-Line therapy. Because gene replacement techniques are currently unavailable for humans, and because even if they were possible the number of people involved would be quite small, the loss of diversity concern seems moot. Finally, we dissuss the issue of iatrogenic disorders associated with gene therapy and discuss several ‘real world considerations.’

Other Versions

No versions found

Similar books and articles

Human Gene therapy: Why draw a line?W. French Anderson - 1989 - Journal of Medicine and Philosophy 14 (6):681-693.
Human Gene therapy: Scientific and ethical considerations.W. French Anderson - 1985 - Journal of Medicine and Philosophy 10 (3):275-292.
Germ-Line Gene Therapy and the Medical Imperative.Ronald Munson & Lawrence H. Davis - 1992 - Kennedy Institute of Ethics Journal 2 (2):137-158.
Should we change the human genome?Torbjörn Tännsjö - 1993 - Theoretical Medicine and Bioethics 14 (3).
Human Gene Therapy.Mary Carrington Coutts - 1994 - Kennedy Institute of Ethics Journal 4 (1):63-83.
Human gene therapy and slippery slope arguments.T. McGleenan - 1995 - Journal of Medical Ethics 21 (6):350-355.
Human gene therapy and the slippery slope argument.Veikko Launis - 2002 - Medicine, Health Care and Philosophy 5 (2):169-179.

Analytics

Added to PP
2010-08-22

Downloads
227 (#178,801)

6 months
60 (#151,785)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Can Enhancement Be Distinguished from Prevention in Genetic Medicine?Eric T. Juengst - 1997 - Journal of Medicine and Philosophy 22 (2):125-142.
Can human genetic enhancement be prohibited?William Gardner - 1995 - Journal of Medicine and Philosophy 20 (1):65-84.
Debunking the slippery slope argument against human germ-line Gene therapy.David Resnik - 1994 - Journal of Medicine and Philosophy 19 (1):23-40.
Embracing Change with All Four Arms: Post-Humanist Defense of Genetic Engineering.J. Hughes - 1996 - Eubios Journal of Asian and International Bioethics 6 (4):94-101.
Enduring Questions and the Ethics of Memory Blunting.Joseph Vukov - 2017 - Journal of the American Philosophical Association 3 (2):227-246.

View all 13 citations / Add more citations

References found in this work

Health as a theoretical concept.Christopher Boorse - 1977 - Philosophy of Science 44 (4):542-573.
On the distinction between disease and illness.Christopher Boorse - 1975 - Philosophy and Public Affairs 5 (1):49-68.
The concept of disease.Joseph Margolis - 1976 - Journal of Medicine and Philosophy 1 (3):238-255.
What is disease?Lester S. King - 1954 - Philosophy of Science 21 (3):193-203.
Gene therapy: ethical and social issues.E. Juengst & L. Walters - forthcoming - Encyclopedia of Bioethics.

Add more references